Austin, Texas, United States, January 5th, 2026, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...
Type 2 diabetes physically alters heart muscle, energy use and structure, a human heart study finds, explaining why people ...
Dr. Mohana Rao Patibandla’s 51-case series highlights safer, minimally invasive parafascicular techniques for deep brain ...
Researchers in China report that a simple heart ultrasound measure of left ventricular underfilling is a valuable prognostic ...
HeartBeam, Inc. , a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that it will attend the JP Morgan 2026 Annual Healthcare ...
According to a recent AHA Scientific Statement, despite ongoing limitations, recent advances in genomic sequencing ...
A decade ago, most people who walked into my clinic with early signs of structural heart changes were in their late forties ...
Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback